Flagship Pioneering
Out of Scope
Bio
Flagship Pioneering Flagship Pioneering, founded in 2000 by Noubar Afeyan PhD (MIT biochemical engineering), manages $14B in AUM with $10.9B in its aggregate capital pool. Fund VIII raised $2.6B in 2024, and $6.4B has been raised since 2021. The venture creation model, where internal scientists invent companies from scratch rather than investing in external startups, is unique in venture capital. The portfolio of 147 companies has created over $100B in aggregate value, with 25 IPOs and 49 acquisit
Industries
Synthetic BiologyBiotechAgriTechAI Infrastructure
Stages
Pre-SeedSeed
Geography
USEurope
Notable investments
- Moderna
- Receptos
- Acceleron Pharma
- Tessera Therapeutics
- Generate:Biomedicines
- Inari Agriculture
- Sana Biotechnology